Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Auris Medical Holding AG (NASDAQ: EARS).

Full DD Report for EARS

You must become a subscriber to view this report.


Recent News from (NASDAQ: EARS)

Auris Medical Holding 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Auris Medical Holding in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 15 2018 14:03
Auris Medical's (EARS) CEO Thomas Meyer on Q1 2018 Results - Earnings Call Transcript
Auris Medical Holding (EARS) Q1 2018 Earnings Conference Call May 15, 2018 8:00 AM ET Executives Hernan Levett – Chief Financial Officer Thomas Meyer – Chairman and Chief Executive Officer Analysts Juan Serrate – Edison Michael Higgins – Ladenbur...
Source: SeekingAlpha
Date: May, 15 2018 13:59
Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results
Expansion of intranasal betahistine program into mental health supportive care Initiating project AM-201 for the treatment of histaminergic receptor mediated weight gain and drowsiness in patients treated with antipsychotic medications Positive scientific advice from EMA on d...
Source: GlobeNewswire
Date: May, 15 2018 06:45
Auris Medical to Report First Quarter 2018 Financial Results and Provide Business and Strategy Update on Tuesday, May 15, 2018
Zug, Switzerland, May 14, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced that it will provide a business and strategy update and report its financial res...
Source: GlobeNewswire
Date: May, 14 2018 07:30
Wired News - Auris Medical Reported Publication Related to AM-111 in Peer-Reviewed Scientific Journal Hearing Research
Stock Monitor: AMAG Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / May 08, 2018 / If you want access to our free research report on Auris Medical Holding AG (NASDAQ: EARS ), all you need to do is sign up now by clicking the following link www.active-investors.com/registrati...
Source: ACCESSWIRE IA
Date: May, 08 2018 07:30
Premarket Gainers as of 9:05 am (05/07/2018)
DARE +29%  on  entering into a merger agreement with Pear Tree Pharmaceuticals. More news on: Dare Bioscience, Inc., Gramercy Property Trust, Inc., Auris Medical Holding, , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 07 2018 09:14
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
Design for single pivotal phase 3 trial validated by European Medicines Agency  Regulatory pathway towards European market approval mapped out Strategy update scheduled together with earnings release for May 15, 2018 Zug, Switzerland, May 7, 2018 - Auris Medical Holding AG ...
Source: GlobeNewswire
Date: May, 07 2018 07:30
Midday Gainers / Losers (05/04/2018)
Gainers:   BSPM +33% . CVGI +35% . CRC +27% . EARS +26% . P +23% . KONA +23% . NGVC +22% . MED +22% . SHAK +22% . PTLA +21% . More news on: Biostar Pharmaceutic, Commercial Vehicle Group, Inc., California Resources Corporation, Stocks on the move, , ...
Source: SeekingAlpha
Date: May, 04 2018 13:15
Auris Medical up 41%
Nano cap Auris Medical ( EARS +40.7% ) is up on a 6x surge in volume in early trade. This morning, it  announced the publication of a summary of non-clinical and clinical data on candidate AM-111 in the journal Hearing Research, hardly enough to justify the action. More news on: ...
Source: SeekingAlpha
Date: May, 04 2018 10:37
Premarket Gainers as of 9:05 am (05/04/2018)
CREG +31% . More news on: China Recycling Energy Corporation, Portola Pharmaceuticals, Euro Tech Holdings Company Limited, , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 04 2018 09:17

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-150.27920.250.27920.235895,695
2018-08-140.270.27750.280.26431,896
2018-08-130.27490.25970.2750.251411,387
2018-08-100.270.251210.270.25212,126
2018-08-090.27240.25910.280.25482,664

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-15153,582421,74536.4158Short
2018-08-1452,333139,44137.5306Short
2018-08-1378,708126,72862.1078Short
2018-08-1019,12237,60650.8483Short
2018-08-09139,327183,80475.8019Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EARS.


About Auris Medical Holding AG (NASDAQ: EARS)

Logo for Auris Medical Holding AG (NASDAQ: EARS)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: EARS)

      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: May, 17 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 15 2018
      Prospectus filed under Rule 424(b)(3)
      Filing Type: 424B3Filing Source: edgar
      Filing Date: May, 15 2018
      Prospectus filed under Rule 424(b)(3)
      Filing Type: 424B3Filing Source: edgar
      Filing Date: May, 11 2018
      Registration statement for certain foreign private issuers
      Filing Type: F-1Filing Source: edgar
      Filing Date: May, 11 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 02 2018
      Withdrawal of registration statement filed under the Securities Act
      Filing Type: RWFiling Source: edgar
      Filing Date: April, 27 2018
      This filing is a pre-effective amendment to an F-1 filing
      Filing Type: F-1/AFiling Source: edgar
      Filing Date: April, 27 2018
      Amendment to a SC 13D filing
      Filing Type: SC 13D/AFiling Source: edgar
      Filing Date: April, 23 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: April, 03 2018

       

       


      Daily Technical Chart for (NASDAQ: EARS)

      Daily Technical Chart for (NASDAQ: EARS)


      Stay tuned for daily updates and more on (NASDAQ: EARS)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: EARS)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EARS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of EARS and does not buy, sell, or trade any shares of EARS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/